Apeiron Investment Group Ltd. - 14 Jul 2022 Form 3 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role: 10%+ Owner
Signature: Apeiron Investment Group Ltd., By: /s/ Julien Hofer, Director
Issuer symbol: SNSE
Transactions as of: 14 Jul 2022
Net transactions value: $0
Form type: 3
Filing time: 20 Jul 2022, 09:53:43 UTC
Previous filing: 02 May 2022
Next filing: 02 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	SNSE	Common Stock						2,483,723	14 Jul 2022	By Apeiron Investment Group Ltd.	F1
holding	SNSE	Common Stock						955,738	14 Jul 2022	By Presight Sensei Co-Invest Fund, L.P.	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The general partner of Presight Sensei Co-Invest Fund, L.P. is Presight Sensei Co-Invest Management, L.L.C., which is a wholly owned subsidiary of Apeiron Investment Group, Ltd. As a result, each of Apeiron Investment Group, Ltd. and Presight Sensei Co-Invest Management, L.L.C. may be deemed to share beneficial ownership of the securities held by Presight Sensei Co-Invest Fund, L.P. Christian Angermayer is the majority shareholder of Apeiron and may be deemed to share beneficial ownership of the securities beneficially owned by Apeiron.

Content

The general partner of Presight Sensei Co-Invest Fund, L.P. is Presight Sensei Co-Invest Management, L.L.C., which is a wholly owned subsidiary of Apeiron Investment Group, Ltd. As a result, each of Apeiron Investment Group, Ltd. and Presight Sensei Co-Invest Management, L.L.C. may be deemed to share beneficial ownership of the securities held by Presight Sensei Co-Invest Fund, L.P. Christian Angermayer is the majority shareholder of Apeiron and may be deemed to share beneficial ownership of the securities beneficially owned by Apeiron.